PRAXIS PRECISION MEDICINES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
PRAXIS PRECISION MEDICINES, INC. (PRAX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 6.82 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 0.00 shares, a 100.00% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 6.82K shares, a 11.54% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 8.21K shares, a 15.87% decline year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 11.80K shares, a 67.06% increase year-over-year.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 36.97K shares, a 10.74% increase from fiscal 2024.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 33.39K shares, a 74.41% decline from fiscal 2023.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 130.47K shares, a 90.22% decline from fiscal 2022.
- PRAXIS PRECISION MEDICINES, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.33M shares, a 120.52% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 6.82K shares 10-Q · filed 2026-08-06 | 15.03K shares derived: sum of 3 quarters · filed 2026-08-06 | 26.83K shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 6.82K shares 10-Q · filed 2026-05-07 | 15.03K shares derived: sum of 2 quarters · filed 2026-05-07 | 26.83K shares derived: sum of 3 quarters · filed 2026-05-07 | 37.68K shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 8.21K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-19 | 20.01K shares derived: sum of 2 quarters · filed 2026-02-19 | 30.86K shares derived: sum of 3 quarters · filed 2026-02-19 | 36.97K shares 10-K · filed 2026-02-19 |
| 2025-09-30 | 11.80K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | 22.65K shares derived: sum of 2 quarters · filed 2025-11-05 | 28.77K shares 10-Q · filed 2025-11-05 | 38.52K shares derived: sum of 4 quarters · filed 2025-11-05 |
| 2025-06-30 | 10.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-04 | 16.96K shares 10-Q · filed 2025-08-04 | 26.72K shares derived: sum of 3 quarters · filed 2025-08-04 | 33.78K shares derived: sum of 4 quarters · filed 2025-08-04 |
| 2025-03-31 | 6.12K shares 10-Q · filed 2025-05-02 | 15.87K shares derived: sum of 2 quarters · filed 2025-05-02 | 22.94K shares derived: sum of 3 quarters · filed 2025-05-02 | 32.15K shares derived: sum of 4 quarters · filed 2025-05-02 |
| 2024-12-31 | 9.76K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | 16.82K shares derived: sum of 2 quarters · filed 2025-02-28 | 26.04K shares derived: sum of 3 quarters · filed 2025-02-28 | 33.39K shares 10-K · filed 2025-02-28 |
| 2024-09-30 | 7.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | 16.28K shares derived: sum of 2 quarters · filed 2024-11-06 | 23.63K shares 10-Q · filed 2024-11-06 | -1.68M shares derived: sum of 4 quarters · filed 2024-11-06 |
| 2024-06-30 | 9.21K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 16.57K shares 10-Q · filed 2024-08-13 | -1.69M shares derived: sum of 3 quarters · filed 2024-08-13 | -1.35M shares derived: sum of 4 quarters · filed 2024-08-13 |
| 2024-03-31 | 7.35K shares 10-Q · filed 2024-05-13 | -1.70M shares derived: sum of 2 quarters · filed 2024-05-13 | -1.36M shares derived: sum of 3 quarters · filed 2024-05-13 | -593.75K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | -1.71M shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | -1.36M shares derived: sum of 2 quarters · filed 2024-03-05 | -601.10K shares derived: sum of 3 quarters · filed 2024-03-05 | 130.47K shares 10-K · filed 2024-03-05 |
| 2023-09-30 | 345.57K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 1.11M shares derived: sum of 2 quarters · filed 2023-11-07 | 1.84M shares 10-Q · filed 2023-11-07 | 2.20M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 761.25K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | 1.49M shares 10-Q · filed 2023-08-09 | 1.85M shares derived: sum of 3 quarters · filed 2023-08-09 | 2.39M shares derived: sum of 4 quarters · filed 2023-08-09 |
| 2023-03-31 | 731.58K shares 10-Q · filed 2023-05-11 | 1.09M shares derived: sum of 2 quarters · filed 2023-05-11 | 1.63M shares derived: sum of 3 quarters · filed 2023-05-11 | 1.90M shares derived: sum of 4 quarters · filed 2023-05-11 |
| 2022-12-31 | 357.89K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | 896.28K shares derived: sum of 2 quarters · filed 2023-02-07 | 1.17M shares derived: sum of 3 quarters · filed 2023-02-07 | 1.33M shares 10-K · filed 2023-02-07 |
| 2022-09-30 | 538.39K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | 810.68K shares derived: sum of 2 quarters · filed 2022-11-09 | 976.23K shares 10-Q · filed 2022-11-09 | 1.17M shares derived: sum of 4 quarters · filed 2022-11-09 |
| 2022-06-30 | 272.29K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 437.83K shares 10-Q · filed 2022-08-08 | 633.71K shares derived: sum of 3 quarters · filed 2022-08-08 | 832.55K shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 165.54K shares 10-Q · filed 2022-05-09 | 361.42K shares derived: sum of 2 quarters · filed 2022-05-09 | 560.26K shares derived: sum of 3 quarters · filed 2022-05-09 | 687.12K shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 195.87K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | 394.72K shares derived: sum of 2 quarters · filed 2022-02-28 | 521.58K shares derived: sum of 3 quarters · filed 2022-02-28 | 604.97K shares 10-K · filed 2022-02-28 |
| 2021-09-30 | 198.84K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | 325.70K shares derived: sum of 2 quarters · filed 2021-11-03 | 409.10K shares 10-Q · filed 2021-11-03 | 494.88K shares derived: sum of 4 quarters · filed 2021-11-03 |
| 2021-06-30 | 126.86K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 210.26K shares 10-Q · filed 2021-08-16 | 296.04K shares derived: sum of 3 quarters · filed 2021-08-16 | |
| 2021-03-31 | 83.40K shares 10-Q · filed 2021-05-11 | 169.18K shares derived: sum of 2 quarters · filed 2021-05-11 | ||
| 2020-12-31 | 85.78K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | 189.51K shares 10-K · filed 2021-03-17 | ||
| 2020-09-30 | 103.73K shares 10-Q · filed 2020-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |